MENU
+Compare
CATX
Stock ticker: ASE
AS OF
Nov 24 closing price
Price
$2.17
Change
+$0.08 (+3.83%)
Capitalization
161.31M

CATX Perspective Therapeutics Forecast, Technical & Fundamental Analysis

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology
CATX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CATX with price predictions
Nov 24, 2025

CATX's RSI Indicator ascending out of oversold territory

The RSI Indicator for CATX moved out of oversold territory on November 17, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In of the 33 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for CATX just turned positive on November 18, 2025. Looking at past instances where CATX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CATX advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CATX as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CATX moved below its 50-day moving average on October 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CATX crossed bearishly below the 50-day moving average on October 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CATX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CATX entered a downward trend on November 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.666) is normal, around the industry mean (63.112). P/E Ratio (0.000) is within average values for comparable stocks, (36.465). CATX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.712). CATX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.000) is also within normal values, averaging (84.419).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CATX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CATX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CATX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CATX is expected to report earnings to rise 3.14% to -36 cents per share on March 26

Perspective Therapeutics CATX Stock Earnings Reports
Q4'25
Est.
$-0.36
Q3'25
Missed
by $0.03
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.30
The last earnings report on November 10 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 1.67M shares outstanding, the current market capitalization sits at 161.31M.
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCCEF0.02N/A
+13.30%
BacTech Environmental Corporation
PLGDF1.070.07
+7.00%
PALISADES GOLDCORP LTD.
GSISF4.010.23
+6.19%
Genesis Minerals Limited
IVEVF4.44N/A
N/A
INVENTIVA SA
SGBLY15.33-0.10
-0.62%
Standard Bank Group Ltd.

CATX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+3.83%
STRR - CATX
88%
Closely correlated
+2.56%
SHC - CATX
36%
Loosely correlated
+2.69%
MTD - CATX
31%
Poorly correlated
+1.22%
RVTY - CATX
29%
Poorly correlated
+2.35%
FLGT - CATX
29%
Poorly correlated
+2.17%
More

Groups containing CATX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+3.83%
Medical/Nursing Services
industry (216 stocks)
22%
Poorly correlated
+2.22%
Health Services
industry (423 stocks)
-3%
Poorly correlated
+1.44%